A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models. [PDF]
PLoS PathogYe Z +13 more
europepmc +1 more source
Generation of peptidomimetic surfaces for biomaterials applications
Generation of peptidomimetic surfaces for biomaterials applications. Biomedical implants are increasingly being used for the treatment of a variety of ailments.
core
In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. [PDF]
PLoS OneKlose M, Weber L, Bachmann HS.
europepmc +1 more source
Cationic Peptoids for Systemic In Vivo Cartilage-Targeting. [PDF]
Adv Sci (Weinh)Zhang C +6 more
europepmc +1 more source
A Three-Layer Transformation Strategy toward Functionalized Fused Hydantoins and Diketopiperazines. [PDF]
Org LettGiannakaki MA +3 more
europepmc +1 more source
Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery? [PDF]
Pharmaceuticals (Basel)Villamil V +4 more
europepmc +1 more source
Covalent Radiopharmaceuticals: Precision Imaging and Therapy for Cancer. [PDF]
Mol PharmKlauser PC, Wang L.
europepmc +1 more source
Structural basis of TMPRSS11D specificity and autocleavage activation. [PDF]
Nat CommunFraser BJ +17 more
europepmc +1 more source
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics. [PDF]
PharmaceuticsScala MC +7 more
europepmc +1 more source
Covalent Peptide-Based N-Myc/Aurora-A Inhibitors Bearing Sulfonyl Fluoride Warheads. [PDF]
J Pept SciDawber RS +6 more
europepmc +1 more source